We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current TARA market cap is 32.47M. The company's latest EPS is USD -3.5351 and P/E is -0.24.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.97M | -39.51M | -9.73M | -12.14M | -10.7M |
| Net Income | -7.69M | -38.97M | -9.05M | -11.29M | -9.86M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.25M | -34.44M | -47.49M | -67.06M | -43.61M |
| Net Income | -14.99M | -33.98M | -47.25M | -65.95M | -40.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 148.59M | 113.29M | 106.41M | 95.14M | 88.47M |
| Total Liabilities | 9.41M | 11.21M | 11.64M | 9.92M | 11.51M |
| Total Equity | 139.18M | 102.08M | 94.77M | 85.23M | 76.96M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.98M | 203.16M | 172.6M | 113.29M | 78.95M |
| Total Liabilities | 583k | 3.91M | 10.68M | 11.21M | 10.63M |
| Total Equity | 6.39M | 199.24M | 161.91M | 102.08M | 68.32M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.43M | -26.46M | -12.89M | -22.3M | -28.86M |
| Investing | 33.3M | 14.95M | 9.86M | 32.21M | 38.59M |
| Financing | -90k | -90k | -64k | -64k | -91k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.65M | -23.41M | -34.5M | -26.46M | -37.56M |
| Investing | 2.48M | 2.84M | -98.19M | 14.95M | 53.11M |
| Financing | N/A | 189.4M | -228k | -90k | -91k |
| Market Cap | 32.47M |
| Price to Earnings Ratio | -0.24 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.24 |
| Price to Book Ratio | 0.14 |
| Dividend Yield | - |
| Shares Outstanding | 11.43M |
| Average Volume (1 week) | 364.06k |
| Average Volume (1 Month) | 626.76k |
| 52 Week Change | -6.88% |
| 52 Week High | 5.10 |
| 52 Week Low | 1.04 |
| Spread (Intraday) | 0.2 (6.67%) |
| Company Name | Protara Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://protaratx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
